United States · 
Who invested in EraGen Biosciences?
EraGen Biosciences's investors include Novartis Venture Fund, Prolog Ventures, First Analysis and Stonehenge Capital.
United States · Series A startup
Who invested in EraGen Biosciences
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$12Mraised across 1 round since 2006, from 1 source
- Latest round
- Series A, $12MJan 2006
- Investors
- 4
The rounds
- Jan 2006Series A$12M
Reported by eragen.com
The exit
ExitBuyerPriceWhen
AcquiredLuminex$34MJun 2011
From historical deal records. Wrong? Tell us.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about EraGen Biosciences
How much has EraGen Biosciences raised?
EraGen Biosciences has raised $12M across 1 round since 2006.
When did EraGen Biosciences last raise?
EraGen Biosciences's most recent round was a Series A of $12M in Jan 2006.
What was EraGen Biosciences's biggest round?
Its most recent round, $12M in Jan 2006, is also its largest on record.
Who backed EraGen Biosciences first?
EraGen Biosciences's first round on record, in Jan 2006, was backed by Novartis Venture Fund, Prolog Ventures and First Analysis and 1 others.
What stage is EraGen Biosciences at?
EraGen Biosciences's latest named round is a Series A, in Jan 2006.
Where is EraGen Biosciences based?
EraGen Biosciences is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.